US Stock Insider Trading | Cibus disclosed 2 insider transactions on February 2

K-LinePoet · 2026-02-04T20:13:50+00:00

Cibus (CBUS) disclosed on February 2, 2026, that director Lehmann Jean-Pierre Jules and shareholder RIGGS RORY B, holding over 10% of shares, made large stock purchases on January 29, purchasing 666,700 shares and 333,300 shares respectively, at a price of $1.50 per share. Cibus is a company focused on food and agriculture, utilizing gene editing technology to develop healthy food ingredients and optimize crop traits.

K-LinePoet

2026-02-04 20:13:50

Abstract generation in progress

On February 2, 2026, Cibus (CBUS) disclosed two insider trading transactions. Director Lehmann Jean-Pierre Jules purchased 666,700 shares on January 29, 2026.

【Recent Insider Transactions】

Disclosure Date	Position	Name	Transaction Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
February 2, 2026	Shareholder with over 10%	RIGGS RORY B	January 29, 2026	Buy	333,300	1.50	500,000
February 2, 2026	Director	Lehmann Jean-Pierre Jules	January 29, 2026	Buy	666,700	1.50	1,000,000
June 11, 2025	Shareholder with over 10%	RIGGS RORY B	June 9, 2025	Buy	50,000	0.01	500.00
June 11, 2025	Shareholder with over 10%	RIGGS RORY B	June 9, 2025	Buy	4,000,000	0.00	400,000.00
June 10, 2025	Shareholder with over 10%	RIGGS RORY B	June 5, 2025	Buy	5,714,300	1.75	17,857,500
February 26, 2025	Director	Prante Gerhard	February 25, 2025	Sell	1,150	1.92	2,208.00
February 25, 2025	Director	Prante Gerhard	February 24, 2025	Sell	1,150	2.07	2,380.50
February 24, 2025	Director	Prante Gerhard	February 21, 2025	Sell	1,150	2.20	2,530.00
February 21, 2025	Director	Prante Gerhard	February 20, 2025	Sell	1,150	2.35	2,702.50
February 20, 2025	Director	Prante Gerhard	February 19, 2025	Sell	1,150	2.58	2,967.00

【Company Information】

Cibus Inc. was incorporated on January 8, 2010, in Delaware and is a wholly owned subsidiary of Cellectis S.A. The company is consumer-focused, with an emphasis on food and agriculture. By combining its core gene editing technology and expertise with its innovative business strategy, the company is pioneering an optimized transformation to provide consumers with healthier food ingredients and farmers with advantageous agricultural traits. The company is developing and commercializing specialty food ingredients such as healthy oils and high-fiber wheat, as well as food crops with desirable traits like herbicide tolerance. While these traits can potentially be achieved through traditional natural and random methods or via conventional agricultural techniques in controlled environments, these processes are imprecise and can take decades or even longer. Their technology enables precise and targeted editing of plant genomes to produce desired traits and characteristics, resulting in final products without foreign DNA. The company believes that the precision, specificity, cost-effectiveness, and rapid development of gene editing technology will enable it to make meaningful disruptions in the food and agriculture industries.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.